We are live on
!
Find out more
MAM
Meeder Asset Management Portfolio holdings
AUM
$1.75B
1-Year Est. Return
34.85%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.55%
AUM
$1.75B
AUM Growth
-$110M
(-5.9%)
Cap. Flow
-$81M
Cap. Flow
% of AUM
-4.64%
Top 10 Holdings %
Top 10 Hldgs %
39.17%
Holding
1,037
New
142
Increased
363
Reduced
297
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$50.1M |
| 2 |
Apple
AAPL
|
+$23.6M |
| 3 |
Mastercard
MA
|
+$20M |
| 4 |
Chevron
CVX
|
+$19.5M |
| 5 |
ExxonMobil
XOM
|
+$15.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$48.8M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$45.3M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$43.8M |
| 4 |
Wintrust Financial
WTFC
|
+$20.4M |
| 5 |
Cardinal Health
CAH
|
+$16.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.12% |
| 2 | Financials | 12.51% |
| 3 | Industrials | 12.37% |
| 4 | Healthcare | 10.8% |
| 5 | Communication Services | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
McCormick & Company Non-Voting
MKC
$14.1B
| $11.1K | ﹤0.01% |
220
+150
| +214% | +$9.55K |
|
|
BIOA
677
BioAge Labs
BIOA
$488M
| $11K | ﹤0.01% |
+631
| New | +$12.2K |
|
678
Corvus Pharmaceuticals
CRVS
$1.17B
| $11K | ﹤0.01% |
+754
| New | +$12K |
|
679
Eastman Chemical
EMN
$8.39B
| $10.9K | ﹤0.01% |
143
+64
| +81% | +$4.61K |
|
680
Genuine Parts
GPC
$18.1B
| $10.8K | ﹤0.01% |
+102
| New | +$12.6K |
|
|
NUVL
681
DELISTED
Nuvalent
NUVL
| $10.8K | ﹤0.01% |
+105
| New | +$10.7K |
|
682
Lifecore Biomedical
LFCR
$167M
| $10.7K | ﹤0.01% |
+2,873
| New | +$19.8K |
|
|
AXON
683
Axon Enterprise
AXON
$49.1B
| $10.6K | ﹤0.01% |
25
-7
| -22% | -$3.64K |
|
684
MasTec
MTZ
$21.4B
| $10.6K | ﹤0.01% |
33
-25
| -43% | -$6.77K |
|
685
Associated Banc-Corp
ASB
$5.95B
| $10.6K | ﹤0.01% |
409
-133
| -25% | -$3.53K |
|
686
Millicom
TIGO
$15.4B
| $10.6K | ﹤0.01% |
141
| – | – |
|
687
Hartford Financial Services
HIG
$39.4B
| $10.5K | ﹤0.01% |
78
-35
| -31% | -$4.78K |
|
688
Burlington
BURL
$23.2B
| $10.4K | ﹤0.01% |
32
-415
| -93% | -$127K |
|
689
Murphy USA
MUSA
$10.7B
| $10.4K | ﹤0.01% |
21
-474
| -96% | -$203K |
|
690
Revolution Medicines
RVMD
$41.9B
| $10.3K | ﹤0.01% |
106
+35
| +49% | +$3.53K |
|
691
Privia Health
PRVA
$3.02B
| $10.3K | ﹤0.01% |
+501
| New | +$11.3K |
|
692
Neurocrine Biosciences
NBIX
$16.4B
| $10.3K | ﹤0.01% |
78
-155
| -67% | -$20.6K |
|
693
Central Pacific Financial
CPF
$1.02B
| $10.3K | ﹤0.01% |
+321
| New | +$10.3K |
|
694
HEICO Corp
HEI
$51.3B
| $10.1K | ﹤0.01% |
+37
| New | +$11.9K |
|
695
Align Technology
ALGN
$12.5B
| $10.1K | ﹤0.01% |
59
+29
| +97% | +$5.08K |
|
696
Veralto
VLTO
$23.7B
| $10.1K | ﹤0.01% |
114
-37
| -25% | -$3.52K |
|
697
Chord Energy
CHRD
$7.32B
| $9.95K | ﹤0.01% |
70
+19
| +37% | +$2.07K |
|
698
Arthur J. Gallagher & Co
AJG
$64.3B
| $9.75K | ﹤0.01% |
45
-14
| -24% | -$3.23K |
|
699
Byline Bancorp
BY
$1.79B
| $9.72K | ﹤0.01% |
+308
| New | +$9.66K |
|
700
Masco
MAS
$15.2B
| $9.72K | ﹤0.01% |
+161
| New | +$10.9K |
|
Similar funds
SFI
DF
CIP
PWP
VCM
PAIM
RIA
NM
Meeder Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Meeder Asset Management held 1,037 positions worth $1.75B, down 5.9% from $1.86B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Meeder Asset Management withdrew a net $81M in Q1 2026, closing 147 positions and reducing 297 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $48.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
Against the trend, Meeder Asset Management opened a new position in State Street SPDR Bloomberg High Yield Bond ETF worth $49.5M.
- Meeder Asset Management's largest Q1 2026 buy was State Street SPDR Bloomberg High Yield Bond ETF: 516,867 shares worth $49.5M.
- Meeder Asset Management added most to Apple in Q1 2026, an estimated $23.6M increase.
- Meeder Asset Management's biggest Q1 2026 reduction was Berkshire Hathaway Class B, cutting an estimated $45.3M.
- Meeder Asset Management fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2026, selling an estimated $48.8M.
- Meeder Asset Management's ten largest holdings make up 39% of its $1.75B portfolio in Q1 2026.
- Meeder Asset Management opened 142 new positions and closed 147 in Q1 2026.
- Meeder Asset Management's portfolio value fell 5.9% quarter-over-quarter to $1.75B.
Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.